Hytrin

📦 Elke bestelling is gedekt door onze Reshipment Assurance Policy — als uw pakket niet binnen 20 werkdagen arriveert, sturen wij het opnieuw.

Waarom bestellen bij MedsBase

Onze generieke medicijnen zijn afkomstig van WHO-GMP gecertificeerde fabrikanten en worden wereldwijd verzonden in discrete, eenvoudige verpakkingen — geen medicijnnaam op de buitenkant van het pakket. Betalingen met kaart worden verwerkt via een gereguleerde processor (betalingsoverzichten vermelden een gereguleerde kaartbetalingprocessor — nooit “MedsBase” of een medicijnnaam). Crypto en SEPA bankoverschrijvingen worden ook geaccepteerd. Elke bestelling wordt ondersteund door ons Reshipment Assurance Policy.

What Is Hytrin?

Hytrin is an oral 1 / 2 / 5 mg Terazosin tablet from AbbVie, supplied in 30-180 tablets. Terazosin was introduced by Abbott (now AbbVie) in 1987 as Hytrin — developed as a longer-acting successor to prazosin, with a 12-hour half-life that permits once-daily dosing. Structurally a close quinazoline analogue of prazosin. Widely used in the 1990s and 2000s for benign prostatic hyperplasia (BPH) and as an add-on antihypertensive; partially displaced by the prostate-selective alpha-1A blockers (tamsulosin, silodosin) for BPH-only use, but retains a strong position where coexisting hypertension makes a non-selective alpha-blocker appropriate.

How Terazosin Works

Terazosin acts on post-synaptic alpha-1 adrenergic receptors on arterial smooth muscle and on prostatic/bladder-neck smooth muscle. De downstream-effecten:

• Arterial and venous vasodilation — blockade of alpha-1 receptors on vascular smooth muscle reduces systemic vascular resistance; venous dilation reduces preload
• Reduced bladder-neck and prostatic smooth-muscle tone — improves urinary flow in BPH (dominant clinical effect for the XL/long-acting forms)
• Improved lipid profile — modest reduction in LDL and triglycerides, small rise in HDL; metabolically distinct from thiazides and beta-blockers
• Improved insulin sensitivity in some studies — an argument for alpha-blockers in hypertensive patients with metabolic syndrome or type 2 diabetes
• No direct effect on renin or electrolytes — potassium, sodium, and creatinine unaffected (contrast with diuretics and RAAS blockers)
• Reflex tachycardia is blunted compared with direct vasodilators (hydralazine, minoxidil) because of some central sympathetic feedback, but still occurs on initiation

Goedgekeurde en evidence-based toepassingen

• Benign prostatic hyperplasia, resistant hypertension as add-on agent
• Benign prostatic hyperplasia — primary indication; once-daily convenience
• Resistente hypertensie as fourth/fifth-line add-on, especially where BPH coexists

Belangrijke klinische onderzoeksresultaten: HYTRIN Community Assessment Trial (HYCAT, 1996) — terazosin improved IPSS by 37% in 2,084 men with symptomatic BPH over 1 year. VA Cooperative BPH Trial (Lepor, NEJM 1996) — terazosin + finasteride no better than terazosin alone in men with smaller prostates, foreshadowing the MTOPS finding that combination therapy helps larger prostates. ALLHAT doxazosin arm (2000) — class-level HF signal.

Hytrin Dosage

Primaire dosering: Hypertensie: start 1 mg at bedtime (first-dose phenomenon risk), titrate every 1-2 weeks up to 5-20 mg/day. The longer half-life vs prazosin makes once-daily dosing practical. Not a first-line antihypertensive. ALLHAT stopped the doxazosin arm early for excess HF; terazosin is extrapolated to the same class concern. Reserve for fourth/fifth-line use, especially where BPH coexists.

Andere indicaties: Benign prostatic hyperplasia: start 1 mg at bedtime, titrate to 5-10 mg once daily over 2-4 weeks. Dose at bedtime indefinitely to minimise orthostatic effects. Symptom benefit typically clear by 4-6 weeks; if inadequate, switch to or add a prostate-selective alpha-1A blocker (tamsulosin) or a 5-alpha-reductase inhibitor (finasteride) for larger prostates (>40 g).

Toediening: take once daily at bedtime. Food does not significantly affect absorption.

Controleschema:

• Uitgangswaarden: supine and standing BP (document postural drop), heart rate, symptom review for dizziness/falls, medication list (check for interacting agents).
• Week 1-2: herhaal bloeddruk (liggend en staand), hartslag, symptoombeoordeling. Pas de dosis aan op basis van bloeddruk en verdraagzaamheid.
• Week 4-6: assess target BP; symptom burden; check for BPH symptom response if applicable (IPSS).
• Doorlopend: annual BP review, fall/syncope history, cataract history (floppy iris pre-op alert).
• Stop of verlaag de dosis bij: syncope, falls, priapism, floppy iris identification, severe retrograde ejaculation affecting quality of life.

Stopzetting: no rebound syndrome. Alpha-blockers can be stopped but expect some BP rise if they contributed meaningfully to control. Re-initiate at the starting dose (not the previous maintenance dose) if restarting after a gap of >1 week — the first-dose phenomenon returns.

Practical Considerations for Hytrin

• Once-daily dosing is a practical advantage over immediate-release prazosin; patients tolerate the regimen better.
• Floppy iris syndrome — warn the ophthalmologist of any terazosin (or other alpha-blocker) exposure before cataract surgery.
• Niet-selectief alpha-1 blockade — tamsulosin and silodosin are more prostate-selective (alpha-1A subtype) and cause less orthostatic hypotension. Use terazosin where coexisting hypertension gives the systemic alpha-1 blockade a secondary benefit.
• Generic terazosin is inexpensive — the molecule is long off-patent; branded Hytrin reflects provenance rather than superior product.
• PDE-5 inhibitor caution — maintain a 4-6 hour gap between terazosin and sildenafil/tadalafil/vardenafil; additive hypotension is severe.

Bijwerkingen

Vaak (>1%):

• Duizeligheid, orthostatische hypotensie (dose-limiting; worst on initiation)
• Asthenia, fatigue
• Hoofdpijn
• Neusverstopping
• Perifeer oedeem
• Somnolence
• Palpitations (reflex tachycardia)
• Retrograde ejaculation (less than with tamsulosin)
• Priapisme (rare)

Zeldzaam maar klinisch belangrijk:

• Syncope with loss of consciousness on first dose or rapid titration — dose at bedtime; warn the patient explicitly.
• Priapisme — emergent urological referral for erection >4 hours.
• Intraoperative floppy iris syndrome — may cause cataract-surgery complications; alert the ophthalmologist.
• Paradoxical urinary incontinence in women (rare; alpha-blockade of bladder-neck tone).
• Worsening of heart failure — class concern from ALLHAT; caution in HF patients.
• Severe hypotension with PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) — maintain a 4-6 hour gap.

Contra-indicaties

• Known hypersensitivity to quinazoline alpha-blockers
• History of significant orthostatic hypotension or unexplained syncope
• Concurrent PDE-5 inhibitors without a strict 4-6 hour gap
• Ernstige aortastenose
• Pregnancy and breastfeeding (limited data)

Zwangerschap: avoided — limited pregnancy data for alpha-blockers. Switch to methyldopa, labetalol, or nifedipine for pregnancy hypertension.

Borstvoeding: limited data; use with caution. Switch to an agent with better breastfeeding data (labetalol, nifedipine, enalapril) where possible.

Geneesmiddelinteracties

• PDE-5 inhibitors (sildenafil, tadalafil, vardenafil) — CRITICAL. Combined use causes severe additive hypotension. Maintain a 4-6 hour gap between alpha-blocker and PDE-5 inhibitor doses; daily-dose tadalafil 5 mg for BPH is contraindicated with alpha-blockers.
• Andere antihypertensiva — additive BP-lowering. Start low, titrate slowly.
• Bètablokkers — reduced reflex tachycardia can mask hypoglycaemia or acute bleed. Combined use is not contraindicated but may require lower alpha-blocker starting dose.
• Non-dihydropyridine CCBs (verapamil, diltiazem) — additive hypotension.
• Diuretica — volume depletion potentiates first-dose hypotension. Hold diuretic the day of first alpha-blocker dose if possible.
• Tricyclic antidepressants — additive orthostatic hypotension.
• NSAID's — reduce antihypertensive effect (less than with thiazides/ACEi).
• Alcohol — marked additive orthostatic hypotension; warn patients.

Where Hytrin Fits in the Antihypertensive Hierarchy

Opslag

Store Hytrin below 25°C in the original blister pack. Keep out of reach of children.

Veelgestelde vragen

Why is Hytrin not a first-line blood-pressure drug?

The ALLHAT trial stopped its doxazosin arm three years early after finding a 25% excess of heart failure compared with chlorthalidone. The finding was interpreted as an alpha-blocker class concern. Guidelines now place ACE inhibitors, ARBs, calcium-channel blockers, and thiazides as first-line, reserving alpha-blockers as fourth or fifth-line agents. Alpha-blockers remain preferred add-ons where benign prostatic hyperplasia (BPH) coexists with hypertension — one drug for two problems.

What is the “first-dose phenomenon” and how do I avoid it?

The first dose of any alpha-blocker can cause severe orthostatic hypotension — blood pressure drops on standing, sometimes to the point of syncope, within 30-90 minutes of the dose. Risk is highest in volume-depleted patients (those already on diuretics) or those on beta-blockers. To minimise risk: take the first dose at bedtime, stay in bed for the first 2-3 hours, avoid alcohol, hold the diuretic dose if possible on day 1, and titrate doses weekly rather than daily. The risk falls sharply over the first 7-10 days as autonomic adaptation occurs.

Can I take Hytrin with alcohol?

Light, occasional drinking is usually tolerated. Regular or heavy drinking substantially potentiates the orthostatic hypotension of Hytrin — falls, blackouts, and accidents become more likely. Patients at higher risk (elderly, previous falls, concurrent diuretics or sedatives) should avoid alcohol altogether on this medication.

How long before my urinary symptoms improve?

Most men notice easier initiation of flow, reduced urgency, and fewer nocturia episodes within 1-2 weken. Full symptom-score benefit (IPSS) usually plateaus at 4-6 weeks. If there is no meaningful improvement by 6-8 weeks on the target dose, switch to or add a prostate-selective alpha-1A blocker (tamsulosin, silodosin) or add a 5-alpha-reductase inhibitor (finasteride, dutasteride) for prostates >40 g. Hytrin does not shrink the prostate; it only reduces the smooth-muscle tone. For larger prostates, combination therapy gives the best durable outcome (MTOPS/CombAT evidence).

Wat als ik een dosis vergeet?

Neem het in zodra u eraan denkt, tenzij het bijna tijd is voor uw volgende dosis — sla in dat geval de gemiste dosis over en hervat op het volgende geplande tijdstip. Neem geen dubbele dosis. Een enkele gemiste dosis heeft geen significant effect op de langetermijncontrole van de bloeddruk.

Can I stop Hytrin if my BP is under control?

Alpha-blockers can be stopped without a dedicated tapering protocol, but BP will usually rise if they contributed meaningfully to control. If restarting after a gap of more than 1 week, re-initiate at the starting dose (not the previous maintenance dose) — the first-dose phenomenon returns after a drug-free break.

Can I take Hytrin in pregnancy?

Generally no. Pregnancy antihypertensives of choice are methyldopa, labetalol, and nifedipine — Hytrin is not first-line in pregnancy. Switch to one of those before conception or as soon as pregnancy is confirmed, under specialist supervision.

Where can I buy Hytrin online?

You can buy Hytrin (1 / 2 / 5 mg terazosin, 30-180 tablets) from MedsBase with discreet packaging and worldwide shipping.

Gerelateerde antihypertensiva op MedsBase

• Aldactone — Spironolacton 25/50/100 mg (PATHWAY-2 4e lijn)
• Amlode — Amlodipine 5/10 mg (CCB)
• Minipress XL — Prazosine ER 2.5/5 mg (Pfizer)
• Prazopress — Prazosin IR 1 mg (Sun Pharma)
• Ramcor — Ramipril 2.5/5/10 mg (ACE-remmer)
• Telma H — Telmisartan + HCTZ combinatie
• Bekijk alle hoge bloeddruk medicijnen

Gerelateerde alternatieven

Andere producten in Chronische aandoeningen die klanten ook bekijken:

• Choltran Sachet
• Nootropil
• Tacroz Forte Ointment
• Ocurest-AH Eye Drops
• Rivamer

Meer opties in medicatie tegen hoge bloeddruk

Gerangschikt op recente bestelvolumes van MedsBase — wat andere klanten in deze categorie kiezen.

Telmaheal

US$9.00 – US$36.00Rango de precios: desde US$9.00 hasta US$36.00

Losar

US$6.53 – US$29.25Rango de precios: desde US$6.53 hasta US$29.25

Amlode

US$5.50 – US$24.00Rango de precios: desde US$5.50 hasta US$24.00

Minoxytop

US$22.00 – US$170.00Rango de precios: desde US$22.00 hasta US$170.00